Antimicrobial stewardship in the outpatient parenteral antimicrobial therapy (OPAT) setting: the impact of prescription assessment by an infectious diseases specialist
- PMID: 33716018
- PMCID: PMC9392152
- DOI: 10.1016/j.bjid.2021.101560
Antimicrobial stewardship in the outpatient parenteral antimicrobial therapy (OPAT) setting: the impact of prescription assessment by an infectious diseases specialist
Abstract
Objective: In recent years, the use of outpatient parenteral antimicrobial therapy (OPAT) has increased, resulting in the need to ensure its rational and adequate utilization. This article describes the implementation of an antimicrobial stewardship program in the OPAT setting by a Health Maintenance Organization (HMO) and its results.
Method: An infectious disease (ID) physician made routine assessments of all home care parenteral antimicrobial requests from February to December 2019. Information on diagnosis, renal function, weight, previous antimicrobials, and microbiology were gathered during remote evaluations. Prescription changes recommended by the ID specialist were not mandatory, but implemented by the primary provider as accepted. Antibiotic consumption data was analyzed from January 2018 to December 2019. An active screening was conducted for treatment failures: two or more treatment course requirements, or death within 15 days of the evaluation were reexamined.
Results: A total of 506 antimicrobial requests were assessed. The most frequent diagnoses were urinary tract infection, pneumonia, and orthopedic surgical site infection. Six percent of evaluations were not completed due to insufficient information and 12% were requests by the primary physician for initial antimicrobial guidance. Of the 416 completed prescriptions evaluations, 58% had suggested changes, including different antimicrobials (40%), treatment duration (25%), and route of administration (23%). There was an increase in use of teicoplanin and meropenem, and a decrease in ceftriaxone, ertapenem, cefepime, amikacin and daptomycin use. The HMO's overall parenteral antimicrobial outpatient consumption, which had shown an upward trend over the previous year, decreased after program initiation. No major adverse results were detected in patients' clinical outcomes; two treatment failures were detected and promptly corrected; no deaths attributed to antibiotic changes were detected.
Conclusion: Outpatient antimicrobial stewardship, through remote assessment by an ID specialist, was effective and safe in the OPAT setting.
Keywords: Antimicrobial stewardship; Home health care; Infectious diseases physician; Outpatient parenteral antibiotic therapy.
Copyright © 2021 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U. All rights reserved.
Figures






Similar articles
-
Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.J Antimicrob Chemother. 2014 Jun;69(6):1695-700. doi: 10.1093/jac/dku015. Epub 2014 Feb 13. J Antimicrob Chemother. 2014. PMID: 24532684
-
Quantifying the Time to Administer Outpatient Parenteral Antimicrobial Therapy: A Missed Opportunity to Compensate for the Value of Infectious Diseases.Clin Infect Dis. 2024 Aug 16;79(2):348-350. doi: 10.1093/cid/ciae262. Clin Infect Dis. 2024. PMID: 38743581 Free PMC article.
-
Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?Infection. 2019 Apr;47(2):169-181. doi: 10.1007/s15010-018-1250-1. Epub 2018 Nov 15. Infection. 2019. PMID: 30443780 Review.
-
The impact of an infectious disease expert team on outpatient parenteral antimicrobial treatment in the Netherlands.Int J Clin Pharm. 2019 Feb;41(1):49-55. doi: 10.1007/s11096-018-0751-4. Epub 2018 Nov 26. Int J Clin Pharm. 2019. PMID: 30478489 Free PMC article.
-
Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists.J Antimicrob Chemother. 2015 Apr;70(4):965-70. doi: 10.1093/jac/dku517. Epub 2014 Dec 23. J Antimicrob Chemother. 2015. PMID: 25538169 Review.
Cited by
-
Outpatient parenteral antimicrobial therapy (OPAT) across the world: a comparative analysis-what lessons can we learn?JAC Antimicrob Resist. 2024 Jul 19;6(4):dlae111. doi: 10.1093/jacamr/dlae111. eCollection 2024 Aug. JAC Antimicrob Resist. 2024. PMID: 39035018 Free PMC article. Review.
-
Delivery of Outpatient Parenteral Antimicrobial Therapy (OPAT) in an Ever-Changing National Health Service (UK): Benefits, Barriers, and Opportunities.Antibiotics (Basel). 2025 Apr 29;14(5):451. doi: 10.3390/antibiotics14050451. Antibiotics (Basel). 2025. PMID: 40426518 Free PMC article. Review.
-
Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program.Antibiotics (Basel). 2022 May 23;11(5):702. doi: 10.3390/antibiotics11050702. Antibiotics (Basel). 2022. PMID: 35625346 Free PMC article.
-
Outpatient parenteral antimicrobial therapy in pediatrics: the role of antimicrobial stewardship.Antimicrob Steward Healthc Epidemiol. 2024 Nov 13;4(1):e203. doi: 10.1017/ash.2024.405. eCollection 2024. Antimicrob Steward Healthc Epidemiol. 2024. PMID: 39563926 Free PMC article.
-
Antimicrobial Stewardship Programs in Latin America and the Caribbean: A Story of Perseverance, Challenges, and Goals.Antibiotics (Basel). 2023 Aug 21;12(8):1342. doi: 10.3390/antibiotics12081342. Antibiotics (Basel). 2023. PMID: 37627762 Free PMC article. Review.
References
-
- Paladino J.A., Poretz D. Outpatient parenteral antimicrobial therapy today. Clin Infect Dis. 2010;51 Suppl 2:S198–S208. - PubMed
-
- Britt R.S., LaSalvia M.T., Padival S., Patel P., McCoyMahoney M.V. Evaluation of inpatient antimicrobial regimens for readmitted outpatient parenteral antimicrobial therapy patients receiving daptomycin or ertapenem for ease of administration. Open Forum Infect Dis. 2019;6 doi: 10.1093/ofid/ofz496. - DOI - PMC - PubMed
-
- Steffens E., Quintens C., Derdelinckx I., Peetermans W.E., Van Eldere J., Spriet I., et al. Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates? Infection. 2019;47(2):169–181. - PubMed
-
- ASS Levin, MBGS Dias, MS Oliveira, LV Perdigão Neto, ARG Vinhole, et al. Guia de utilização de anti-infecciosos e recomendações para a prevenção de infecções relacionadas a assistência à saúde 2018-2020. São Paulo, Brazil: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo; 2018.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical